- Home
- CCEL vs MLSS Comparison
CCEL vs MLSS Comparison
Compare CCEL & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- MLSS
- Stock Information
- Founded
- CCEL 1989
- MLSS 1989
- Country
- CCEL United States
- MLSS United States
- Employees
- CCEL N/A
- MLSS N/A
- Industry
- CCEL Managed Health Care
- MLSS Industrial Specialties
- Sector
- CCEL Health Care
- MLSS Health Care
- Exchange
- CCEL Nasdaq
- MLSS Nasdaq
- Market Cap
- CCEL 39.9M
- MLSS 42.4M
- IPO Year
- CCEL 1997
- MLSS 1995
- Fundamental
- Price
- CCEL $4.90
- MLSS $0.64
- Analyst Decision
- CCEL Strong Buy
- MLSS Buy
- Analyst Count
- CCEL 1
- MLSS 1
- Target Price
- CCEL $8.50
- MLSS $1.25
- AVG Volume (30 Days)
- CCEL 7.1K
- MLSS 942.3K
- Earning Date
- CCEL 07-15-2025
- MLSS 08-22-2025
- Dividend Yield
- CCEL 12.50%
- MLSS N/A
- EPS Growth
- CCEL N/A
- MLSS N/A
- EPS
- CCEL N/A
- MLSS N/A
- Revenue
- CCEL $31,988,783.00
- MLSS $8,613,503.00
- Revenue This Year
- CCEL $1.75
- MLSS $25.28
- Revenue Next Year
- CCEL N/A
- MLSS $20.75
- P/E Ratio
- CCEL N/A
- MLSS N/A
- Revenue Growth
- CCEL 1.10
- MLSS N/A
- 52 Week Low
- CCEL $4.68
- MLSS $0.38
- 52 Week High
- CCEL $9.43
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- CCEL 48.00
- MLSS 53.53
- Support Level
- CCEL $4.75
- MLSS $0.50
- Resistance Level
- CCEL $5.43
- MLSS $0.68
- Average True Range (ATR)
- CCEL 0.26
- MLSS 0.07
- MACD
- CCEL 0.01
- MLSS 0.02
- Stochastic Oscillator
- CCEL 28.38
- MLSS 86.50
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.